Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'DISEASE EXTENT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 37 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Carruthers, D; Bacon, P
      Activity, damage and outcome in systemic vasculitis

      BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    2. de Groot, K; Gross, WL; Herlyn, K; Reinhold-Keller, E
      Development and validation of a disease extent index for Wegener's granulomatosis

      CLINICAL NEPHROLOGY
    3. Medinger, AE; Khouri, S; Rohatgi, PK
      Sarcoidosis - The value of exercise testing

      CHEST
    4. Sobin, LH
      Principles, history, and relation to other prognostic factors

      CANCER
    5. Nozue, T; Kobayashi, A; Takagi, Y; Okabe, H; Hasegawa, M
      Assessment of disease activity and extent by magnetic resonance imaging inulcerative colitis

      PEDIATRICS INTERNATIONAL
    6. Pujol, JL; Greiner, J; Boher, JM; Quantin, X; Parrat, E; Daures, JP
      New data regarding serum markers in lung cancer.

      REVUE DES MALADIES RESPIRATOIRES
    7. Herlyn, K; Gross, WL; Reinhold-Keller, E
      Prognostic factors and outcome in primary systemic vasculitides in Germany

      ZEITSCHRIFT FUR RHEUMATOLOGIE
    8. Lamy, PJ; Grenier, J; Kramar, A; Pujol, JL
      Pro-gastrin-releasing peptide, neuron specific enolase and chromogranin A as serum markers of small cell lung cancer

      LUNG CANCER
    9. Mayer, D; Reinshagen, M; Mason, RA; Muche, R; von Tirpitz, C; Eckelt, D; Adler, G; Beckh, K; Kratzer, W
      Sonographic measurement of thickened bowel wall segments as a quantitativeparameter for activity in inflammatory bowel disease

      ZEITSCHRIFT FUR GASTROENTEROLOGIE
    10. Suzuki, H; Takayanagi, S; Otake, T; Ishibashi, R; Osawa, S; Shirai, T; Takashima, M; Hanai, H; Kaneko, E
      Primary small cell carcinoma of the esophagus with achalasia in a patient in whom pro-gastrin-releasing peptide and neuron-specific enolase levels reflected the clinical course during chemotherapy

      JOURNAL OF GASTROENTEROLOGY
    11. Sunaga, N; Tsuchiya, S; Minato, K; Watanabe, S; Fueki, N; Hoshino, H; Makimoto, T; Ishihara, S; Saito, R; Mori, M
      Serum pro-gastrin-releasing peptide is a useful marker for treatment monitoring and survival in small-cell lung cancer

      ONCOLOGY
    12. Redwine, DB
      Ovarian endometriosis: a marker for more extensive pelvic and intestinal disease

      FERTILITY AND STERILITY
    13. DEGROOT K; GROSS WL
      WEGENERS GRANULOMATOSIS - DISEASE COURSE, ASSESSMENT OF ACTIVITY AND EXTENT AND TREATMENT

      Lupus
    14. MILLERON B
      NEURON-SPECIFIC ENOLASE

      Revue des maladies respiratoires
    15. PINSON P; JOOS G; WATRIPONT P; BRUSSELLE G; PAUWELS R
      SERUM NEURON-SPECIFIC ENOLASE AS A TUMOR-MARKER IN THE DIAGNOSIS AND FOLLOW-UP OF SMALL-CELL LUNG-CANCER

      Respiration
    16. TAMPELLINI M; BERRUTI A; GERBINO A; BUNIVA T; TORTA M; GORZEGNO G; FAGGIUOLO R; CANNONE R; FARRIS A; DESTEFANIS M; MORO G; DELTETTO F; DOGLIOTTI L
      RELATIONSHIP BETWEEN CA-15-3 SERUM LEVELS AND DISEASE EXTENT IN PREDICTING OVERALL SURVIVAL OF BREAST-CANCER PATIENTS WITH NEWLY-DIAGNOSED METASTATIC DISEASE

      British Journal of Cancer
    17. JORGENSEN LGM; PRENTO P; JENSEN G
      NEURON-SPECIFIC ENOLASE (NSE) AND THE NEUROENDOCRINE AND CYTOGENETIC CHANGES OF SMALL LUNG-CANCER (SCLC) CELL-LINES DURING CHEMOTHERAPY

      Journal of tumor marker oncology
    18. PAPOS M; VARKONYI A; LANG J; BUGA K; TIMAR E; POLGAR M; BODI I; CSERNAY L
      HM-PAO-LABELED LEUKOCYTE SCINTIGRAPHY IN PEDIATRIC-PATIENTS WITH INFLAMMATORY BOWEL-DISEASE

      Journal of pediatric gastroenterology and nutrition
    19. ADAMUS G; APTSIAURI N; GUY J; HECKENLIVELY J; FLANNERY J; HARGRAVE PA
      THE OCCURRENCE OF SERUM AUTOANTIBODIES AGAINST ENOLASE IN CANCER-ASSOCIATED RETINOPATHY

      Clinical immunology and immunopathology
    20. LANGHOLZ E; MUNKHOLM P; DAVIDSEN M; NIELSEN OH; BINDER V
      CHANGES IN EXTENT OF ULCERATIVE-COLITIS - A STUDY ON THE COURSE AND PROGNOSTIC FACTORS

      Scandinavian journal of gastroenterology
    21. HE Y; LAM TH; LI LS; LI LS; DU RY; JIA GL; HUANG JY; ZHENG JS
      THE NUMBER OF STENOTIC CORONARY-ARTERIES AND PASSIVE SMOKING EXPOSUREFROM HUSBAND IN LIFELONG NONSMOKING WOMEN IN XIAN, CHINA

      Atherosclerosis
    22. LAI RS; HSU HK; LU JY; GER LP; LAI NS
      CYFRA-21-1 ENZYME-LINKED-IMMUNOSORBENT-ASSAY - EVALUATION AS A TUMOR-MARKER IN NON-SMALL-CELL LUNG-CANCER

      Chest
    23. JORGENSEN LGM; OSTERLIND K; GENOLLA J; GOMM SA; HERNANDEZ JR; JOHNSON PWM; LOBER J; SPLINTER TAW; SZTURMOWICZ M
      SERUM NEURON-SPECIFIC ENOLASE (S-NSE) AND THE PROGNOSIS IN SMALL-CELLLUNG-CANCER (SCLC) - A COMBINED MULTIVARIABLE ANALYSIS ON DATA FROM 9CENTERS

      British Journal of Cancer
    24. TAKADA M; KUSUNOKI Y; MASUDA N; MATUI K; YANA T; USHIJIMA S; IIDA K; TAMURA K; KOMIYA T; KAWASE I; KIKUI N; MORINO H; FUKUOKA M
      PRO-GASTRIN-RELEASING PEPTIDE(31-98) AS A TUMOR-MARKER OF SMALL-CELL LUNG-CANCER - COMPARATIVE-EVALUATION WITH NEURON-SPECIFIC ENOLASE

      British Journal of Cancer
    25. MEUNIER PJ; VIGNOT E
      THERAPEUTIC STRATEGY IN PAGETS-DISEASE OF BONE

      Bone
    26. JORGENSEN T; MULLER C; KAALHUS O; DANIELSEN HE; TVETER KJ
      EXTENT OF DISEASE BASED ON INITIAL BONE-SCAN - IMPORTANT PROGNOSTIC PREDICTOR FOR PATIENTS WITH METASTATIC PROSTATIC-CANCER - EXPERIENCE FROM THE SCANDINAVIAN PROSTATIC-CANCER GROUP-STUDY NO-2 (SPCG-2)

      European urology
    27. YILMAZLAR T; ZORLUOGLU A; OZGUC H; KORUN N; DUMAN H; KAYA E; KIZIL A
      COLORECTAL-CANCER IN YOUNG-ADULTS

      Tumori
    28. OKTAY G; GUNER G; KARLIKAYA C; AKKOCLU A
      SERUM LEVELS OF NEURON-SPECIFIC ENOLASE, CARBOHYDRATE ANTIGEN-19-9 AND CARBOHYDRATE ANTIGEN-125 IN CARCINOMA OF THE LUNG

      Biochemical Society transactions
    29. TAKADA M; MASUDA N; MATSUURA E; KUSUNOKI Y; MATUI K; NAKAGAWA K; YANA T; TUYUGUCHI I; OOHATA I; FUKUOKA M
      MEASUREMENT OF CYTOKERATIN 19 FRAGMENTS AS A MARKER OF LUNG-CANCER BYCYFRA-21-1 ENZYME-IMMUNOASSAY

      British Journal of Cancer
    30. PREVOST A; PASSEMARD F; PERDU D; VALLERAND H; DESCHAMPS F; LAVAUD F; LARBRE H
      THE VALUE OF MEASURING SERUM TPA LEVELS I N BRONCHOPULMONARY CANCER -A COMPARATIVE-STUDY WITH ACE, CA 19.9 AND NSE LEVELS

      Revue des maladies respiratoires
    31. WAALER G; NILSSEN MO
      PROGNOSTIC FACTORS IN DISSEMINATED PROSTATIC-CANCER, WITH SPECIAL EMPHASIS ON EXTENT OF DISEASE

      Urologia internationalis
    32. JORGENSEN LGM; OSTERLIND K; HANSEN HH; COOPER EH
      SERUM NEURON-SPECIFIC ENOLASE (S-NSE) IN PROGRESSIVE SMALL-CELL LUNG-CANCER (SCLC)

      British Journal of Cancer
    33. EBERT W; MULEY T; WASSENBERG D
      NSE IN THE PRIMARY DIAGNOSIS OF SMALL-CELL LUNG-CANCER - COMPARISON OF THE NEW DELFIA NSE WITH THE RIA TECHNIQUE

      Tumordiagnostik & Therapie
    34. GROSS AJ; MICHL UHG; BORNHOFT G; DIECKMANN KP
      NEURON-SPECIFIC ENOLASE - A SERUM TUMOR-MARKER IN RENAL-CELL CARCINOMA

      European urology
    35. GROSS AJ; DIECKMANN KP
      NEURON-SPECIFIC ENOLASE - A SERUM TUMOR-MARKER IN MALIGNANT GERM-CELLTUMORS

      European urology
    36. RASMUSON T; GRANKVIST K; LJUNGBERG B
      SERUM GAMMA-ENOLASE AND PROGNOSIS OF PATIENTS WITH RENAL-CELL CARCINOMA

      Cancer
    37. ARPIN D; TRILLETLENOIR V; LASSET C; SOUQUET PJ; RIOU R; YOANIDIS I; GUIDOLLET J; CORDIER JF; BRUNE J
      INTEREST OF C-REACTIVE PROTEIN ASSAY IN S MALL-CELL LUNG-CANCER

      Bulletin du cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 16:31:03